Skip to main content

Infectious Dermatology

Infectious Dermatology

Featured

Derm Q&A
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an interview with The Dermatologist, Esther Freeman, MD, PhD, principle investigator, discussed the COVID-19 Dermatology registry in collaboration with the American Academy of Dermatology (AAD) and what the AAD hope to learn from providers across disciplines who are submitting cases.
Online Exclusive
Derm Q&A
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an intervie
Cover Story
Coronavirus disease, or COVID-19, may still be novel to the dermatology community, but research since its initial appearance in humans have elucidated some of the mystery around the virology and epidemiology of SARS-CoV-2.
Derm Q&A
Jules Lipoff, MD, spoke with The Dermatologist about treating patients with blistering autoimmune disease during the COVID-19 pandemic, including treatment considerations and common questions patients
Back to Top